| Literature DB >> 15277532 |
Xuehui Yang1, Dmitry Kovalenko, Robert J Nadeau, Lauren K Harkins, Jane Mitchell, Olga Zubanova, Pei-Yu Chen, Robert Friesel.
Abstract
Sef was recently identified as a negative regulator of fibroblast growth factor (FGF) signaling in a genetic screen of zebrafish and subsequently in mouse and humans. By inhibiting FGFR1 tyrosine phosphorylation and/or Ras downstream events, Sef inhibits FGF-mediated ERK activation and cell proliferation as well as PC12 cell differentiation. Here we show that Sef and a deletion mutant of Sef lacking the extracellular domain (SefIC) physically interact with TAK1 (transforming growth factor-beta-associated kinase) and activate JNK through a TAK1-MKK4-JNK pathway. Sef and SefIC overexpression also resulted in apoptotic cell death, while dominant negative forms of MKK4 and TAK1 blocked Sef-mediated JNK activation and attendant 293T cell apoptosis. These investigations reveal a novel activating function of Sef that is distinct from its inhibitory effect on FGF receptor signaling and ERK activation.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15277532 DOI: 10.1074/jbc.C400318200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157